| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Issuance( Retirement)of Debt Net | -0.09 | 12.46 | -1.86 | -6.99 |
| Net Changein Cash | 0.11 | -4.86 | 1.60 | 3.12 |
| Cash Taxes Paid | 15.15 | 20.88 | 18.65 | 9.72 |
| Net Income/ Starting Line | 86.98 | 79.76 | 77.09 | 57.04 |
| Total Cash Dividends Paid | -12.16 | -11.50 | -8.30 | -7.63 |
| Changesin Working Capital | -19.63 | -30.65 | 24.81 | -3.97 |
| Cashfrom Operating Activities | 104.93 | 68.19 | 108.96 | 60.96 |
| Cash Interest Paid | 4.83 | 4.38 | 1.11 | 0.79 |
| Cashfrom Financing Activities | -13.03 | 1.01 | -15.29 | -43.74 |
| Depreciation/ Depletion | 30.74 | 27.99 | 13.44 | 12.36 |
| Other Investing Cash Flow Items Total | -24.13 | -21.87 | -54.38 | 56.78 |
| Capital Expenditures | -67.66 | -52.19 | -37.68 | -70.89 |
| period Type | - | - | - | - |
| Non- Cash Items | 6.85 | -8.91 | -6.38 | -4.47 |
| Financing Cash Flow Items | -0.78 | 0.04 | -1.11 | -1.92 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Cashfrom Investing Activities | -91.79 | -74.06 | -92.07 | -14.11 |
| Issuance( Retirement)of Stock Net | - | 0.00 | -4.02 | -27.19 |
Windlas Biotech Dividend Windlas Biotech Bonus Windlas Biotech News Windlas Biotech AGM Windlas Biotech Rights Windlas Biotech Splits Windlas Biotech Board Meetings Windlas Biotech Key Metrics Windlas Biotech Shareholdings Windlas Biotech Profit Loss Windlas Biotech Balance Sheet Windlas Biotech Q1 Results Windlas Biotech Q2 Results Windlas Biotech Q3 Results Windlas Biotech Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.